Quick Answer
Apyx Medical Corp reported Revenue (ASC 606) of $52.35 million for fiscal year 2023.
Apyx Medical Corp Revenue (ASC 606) — Annual History
| Fiscal Year | Revenue (ASC 606) | YoY Change |
|---|---|---|
| 2023 | $52.35M | +17.6% |
| 2022 | $44.51M | -8.3% |
| 2021 | $48.52M | +75.1% |
| 2020 | $27.71M | -1.9% |
| 2019 | $28.23M | +70.0% |
| 2018 | $16.61M | +62.3% |
| 2017 | $10.23M | — |
Quarterly Revenue (ASC 606)
| Quarter Ending | Revenue (ASC 606) | YoY | QoQ |
|---|---|---|---|
| June 30, 2024 | $12.15M | -10.5% | +18.6% |
| March 31, 2024 | $10.24M | -15.6% | -14.5% |
| September 30, 2023 | $11.98M | +31.4% | -11.7% |
| June 30, 2023 | $13.57M | +31.8% | +11.8% |
| March 31, 2023 | $12.14M | -2.8% | +33.2% |
| September 30, 2022 | $9.11M | -23.0% | -11.4% |
| June 30, 2022 | $10.29M | -8.3% | -17.6% |
| March 31, 2022 | $12.49M | +44.6% | +5.6% |
- Apyx Medical Corp showed an increase of +17.6% in Revenue (ASC 606) compared to the prior fiscal year.
- Over the 2017–2023 period, Apyx Medical Corp’s revenue (asc 606) has grown by 411.5% (from $10.23 million to $52.35 million).
- The most recent figure is from Apyx Medical Corp’s fiscal year 2023 report (Form 10-K), filed with the SEC on March 21, 2024.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: